Diary - News All news MaaT Pharma Presents Product Analysis

MaaT Pharma Presents Product Analysis

MaaT Pharma Presents Product Analysis of its First-in-class High Diversity Microbiome Therapeutic at 2018 EMBO Symposium on The Human Microbiome

Results from in silico analysis using MaaT Pharma’s data analysis platform, GutPrint, demonstrate therapeutic rationale and manufacturing capabilities of developing a high diversity biological drug product.

Read the press release

To go further...

See Maat Pharma profil

Headlines

Our members

Adocia renforce sa trésorerie de 19 millions d’euros à la suite d’une opération immobilière

March 29^th, 2022

Cellenion Announces Opening of BICO’s First Single Cell Analysis Centre of Excellence

March 9^th, 2022

Carthera's SonoCloud technology demonstrates safety and therapeutic potential